Basit öğe kaydını göster

dc.contributor.authorKocazeybek, B
dc.contributor.authorBahar, H
dc.contributor.authorTorun, MM
dc.contributor.authorDemirci, M
dc.date.accessioned2021-03-05T09:38:10Z
dc.date.available2021-03-05T09:38:10Z
dc.date.issued2005
dc.identifier.citationBahar H., Torun M., Demirci M., Kocazeybek B., "Antimicrobial resistance and beta-lactamase production of clinical isolates of Prevotella and Porphyromonas species", CHEMOTHERAPY, cilt.51, ss.9-14, 2005
dc.identifier.issn0009-3157
dc.identifier.otherav_9ec78a82-a8c1-4b7f-a7ab-e3f5340304e1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/106617
dc.identifier.urihttps://doi.org/10.1159/000084017
dc.description.abstractBackground: This study determined the beta-lactamase production and the antimicrobial resistance of 72 Prevotella species and 48 Porphyromonas species isolated from different clinical specimens. Methods: All strains were identified using API 32 ID. The beta-lactamase production was determined by nitrocefin disks. E test strips of benzylpenicillin, ampicillin + sulbactam, cefoxitin, clindamycin, metronidazole and imipenem were tested for each strain. Results: Nineteen Prevotella melaninogenica, 18 Prevotella intermedia, 16 Prevotella denticola, 11 Prevotella loescheii and 8 Prevotella bivia strains were identified. Four were clindamycin resistant. The highest beta-lactamase production was found at a rate of 68.4% in P. melaninogenica species. Additionally, 33 Porphyromonas asaccharolytica and 15 Porphyromonas gingivalis strains were identified. None of them produced beta-lactamase. Conclusion: In view of the emerging antibiotic resistance among anaerobes, the current local susceptibility profile of our Prevotella and Porphyromonas species will establish the basis for additional surveys tracing significant changes in the antimicrobial resistance of our clinical isolates. Copyright (C) 2005 S. Karger AG, Basel.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectTemel Eczacılık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.titleAntimicrobial resistance and beta-lactamase production of clinical isolates of Prevotella and Porphyromonas species
dc.typeMakale
dc.relation.journalCHEMOTHERAPY
dc.contributor.department, ,
dc.identifier.volume51
dc.identifier.issue1
dc.identifier.startpage9
dc.identifier.endpage14
dc.contributor.firstauthorID20963


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster